Discover the interview of Ziad Julier, co-founder of start-up Orio Therapeutics, based at the BioArk in Monthey, on Radio Chablais.
Ziad presents their new cardio-protective drug technology, currently in the development phase, and his entrepreneurial journey.
“Our ultimate goal is for an acute patient who has had a heart attack to be able, thanks to our treatment, to return to his or her normal life without any after-effects.”
Know more : Find out more on their new technology, developed by Orio Therapeutics co-founders Dr. Ziad Julier and Associate Professor Mikaël Martino, both of the Australian Regenerative Medicine Institute (ARMI) in the MNHS Faculty at Monash University, modifies therapeutic proteins to improve delivery, through controlled, slow release and consistent dosing that remains at the injection site, enabling better therapeutic effects at lower doses.
